For the treatment of canine congestive heart failure originating from
dilated cardiomyopathy or valvular insufficiency (mitral and
or
tricuspid valve regurgitation).
For the treatment of dilated cardiomyopathy in the preclinical stage
-(asymptomatic with an increase in left ventricular end
diastolic diameter) in Doberman Pinschers following echocardiographic
diagnosis of cardiac disease.
For the treatment of dogs with myxomatous mitral valve disease (MMVD) in
the preclinical stage (asymptomatic with a systolic mitral murmur and
evidence of increased heart size) to delay the onset of clinical
symptoms of heart failure
£28.57
Click here to find expanded datasheet with further product information